Celltrion Covid

South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...

The number of Netflix users in South Korea has decreased by more than 30% in the past year since the recovery from COVID-19. According to Byun Jae-...

Resuming flights from Incheon International Airport to and from Prague, Czech Republic, and Zurich, Switzerland, to expand its air traffic, South Ko...

Woowa Brothers Corp., the operator of South Korea’s top food delivery app, posted a record profit in 2022, which also marked its first profit ...

South Korea’s mandatory quarantine for confirmed COVID-19 patients from May will be cut from seven days to five, as the country is expected to...

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

South Korean biosimilar giant Celltrion Group’s founder Seo Jung-jin has returned to management two years after his departure, pledging to mer...

E-Mart24 Inc., the convenience store chain unit of Shinsegae Inc. Group, announced on Tuesday that it will resume the value-added tax (VAT) refund s...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...

South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...

Coex Convention & Exhibition Center, the largest event complex in Seoul, was crowded on Friday for a smart factory and plant automation fair.&ld...

SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...

South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...

South Korea’s low-income households are feeling the pinch of rising food prices amid the COVID-19 pandemic, according to a report by a local t...

South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...

South Korean companies have witnessed a sharp increase in alleged trademark piracy in China over the past few years, as COVID-19 curbed their overse...

South Korea's department store group Galleria Department Store said on Tuesday that for the past six months (between August last year and January th...

Jeju Air Co., a South Korean budget airline, said on Thursday that it would resume its flights connecting Incheon with two small cities in Japan, Ma...

Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...

Celltrion Inc. has secured an additional stake in the UK's antibody-drug conjugate (ADC) developer Iksuda Therapeutics.According to Celltrion on Wed...

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...

South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...

South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...

South Korea's KB Asset Management Co. is set to sell two three-star hotel buildings in Myeong-dong, one of the most popular spots for foreign touris...

Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...

South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...

Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...